These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 12771128

  • 1. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
    Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO, Dejana E.
    J Cell Biol; 2003 May 26; 161(4):793-804. PubMed ID: 12771128
    [Abstract] [Full Text] [Related]

  • 2. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R, Abraham D, Paulus P, Blumer R, Grimm M, Wojta J, Aharinejad S.
    Circulation; 2003 Sep 30; 108(13):1585-91. PubMed ID: 12963640
    [Abstract] [Full Text] [Related]

  • 3. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y.
    Diabetologia; 2003 Jan 30; 46(1):115-23. PubMed ID: 12637990
    [Abstract] [Full Text] [Related]

  • 4. Regulation of VE-cadherin linkage to the cytoskeleton in endothelial cells exposed to fluid shear stress.
    Ukropec JA, Hollinger MK, Woolkalis MJ.
    Exp Cell Res; 2002 Feb 15; 273(2):240-7. PubMed ID: 11822879
    [Abstract] [Full Text] [Related]

  • 5. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
    Yamaoka-Tojo M, Tojo T, Kim HW, Hilenski L, Patrushev NA, Zhang L, Fukai T, Ushio-Fukai M.
    Arterioscler Thromb Vasc Biol; 2006 Sep 15; 26(9):1991-7. PubMed ID: 16763158
    [Abstract] [Full Text] [Related]

  • 6. VE-cadherin increases the half-life of VEGF receptor 2.
    Calera MR, Venkatakrishnan A, Kazlauskas A.
    Exp Cell Res; 2004 Oct 15; 300(1):248-56. PubMed ID: 15383331
    [Abstract] [Full Text] [Related]

  • 7. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
    Qi JH, Claesson-Welsh L.
    Exp Cell Res; 2001 Feb 01; 263(1):173-82. PubMed ID: 11161716
    [Abstract] [Full Text] [Related]

  • 8. VEGF protects bovine aortic endothelial cells from TNF-alpha- and H2O2-induced apoptosis via co-modulatory effects on p38-and p42/p44-CCDPK signaling.
    Liu WL, Guo X, Chen QQ, Guo ZG.
    Acta Pharmacol Sin; 2002 Jan 01; 23(1):45-9. PubMed ID: 11860736
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T.
    Circ Res; 2003 Sep 05; 93(5):438-47. PubMed ID: 12881481
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin).
    Caveda L, Martin-Padura I, Navarro P, Breviario F, Corada M, Gulino D, Lampugnani MG, Dejana E.
    J Clin Invest; 1996 Aug 15; 98(4):886-93. PubMed ID: 8770858
    [Abstract] [Full Text] [Related]

  • 11. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
    Wallez Y, Cand F, Cruzalegui F, Wernstedt C, Souchelnytskyi S, Vilgrain I, Huber P.
    Oncogene; 2007 Feb 15; 26(7):1067-77. PubMed ID: 16909109
    [Abstract] [Full Text] [Related]

  • 12. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells.
    Wright TJ, Leach L, Shaw PE, Jones P.
    Exp Cell Res; 2002 Nov 01; 280(2):159-68. PubMed ID: 12413882
    [Abstract] [Full Text] [Related]

  • 13. MAP kinase and beta-catenin signaling in HGF induced RPE migration.
    Liou GI, Matragoon S, Samuel S, Behzadian MA, Tsai NT, Gu X, Roon P, Hunt DM, Hunt RC, Caldwell RB, Marcus DM.
    Mol Vis; 2002 Dec 20; 8():483-93. PubMed ID: 12500177
    [Abstract] [Full Text] [Related]

  • 14. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
    Wang J, Morita I, Onodera M, Murota SI.
    J Cell Physiol; 2002 Feb 20; 190(2):238-50. PubMed ID: 11807828
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
    Lin MT, Yen ML, Lin CY, Kuo ML.
    Mol Pharmacol; 2003 Nov 20; 64(5):1029-36. PubMed ID: 14573751
    [Abstract] [Full Text] [Related]

  • 16. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R, Gingras D, Kruger EA, Lamy S, Sirois P, Simard B, Sirois MG, Tranqui L, Baffert F, Beaulieu E, Dimitriadou V, Pépin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E.
    Clin Cancer Res; 2002 Apr 20; 8(4):1242-50. PubMed ID: 11948139
    [Abstract] [Full Text] [Related]

  • 17. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.
    Gingras D, Lamy S, Béliveau R.
    Biochem J; 2000 Jun 01; 348 Pt 2(Pt 2):273-80. PubMed ID: 10816419
    [Abstract] [Full Text] [Related]

  • 18. Opposing effect of angiopoietin-1 on VEGF-mediated disruption of endothelial cell-cell interactions requires activation of PKC beta.
    Wang Y, Pampou S, Fujikawa K, Varticovski L.
    J Cell Physiol; 2004 Jan 01; 198(1):53-61. PubMed ID: 14584044
    [Abstract] [Full Text] [Related]

  • 19. VEGF-dependent signaling in retinal microvascular endothelial cells.
    Enaida H, Kabuyama Y, Oshima Y, Sakamoto T, Kato K, Kochi H, Homma Y.
    Fukushima J Med Sci; 1999 Dec 01; 45(2):77-91. PubMed ID: 11039605
    [Abstract] [Full Text] [Related]

  • 20. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, Taylor RN, Fantl WJ.
    Cancer Res; 2003 Jun 15; 63(12):3145-53. PubMed ID: 12810642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.